(Other OTC:AONC),(OTC US:AONC), BETHESDA, Md., Aug. 07, 2025 (GLOBE NEWSWIRE) — American Oncology Network (AON), one of the nation's fastest-growing networks of community-based oncology practices, and its partner practice, The Center for Cancer and Blood Disorders (CCBD), are pleased to welcome Board-certified medical oncologists Garrett Diltz, MD, and Shreya Desai, MD, to the care team. […]

(CNSX:TRUE.CN),(OTC US:TREIF),(OTCQB:TREIF),(Boerse Frankfurt – Freiverkehr:939), 2024 marked the worst year on record for ER closures in Ontario, with 1 in 5 hospitals experiencing unplanned shutdowns, especially in rural areas. Ontario's family physician workforce is aging, with 15% of patients attached to doctors nearing retirement and 2.5 million Ontarians lacking a family doctor as of 2023.

Salvador Galván, CEO of Canarias Tecnológica y Sistemas de Información (CTSI), has been named twice in the 2025 Business Worldwide Magazine CEO Awards, winning two prestigious titles: “Most Innovative CEO in Public Sector Digital Transformation – Spain” and “Visionary CEO in Public Sector Technology & Innovation.” Business Worldwide Magazines CEO Awards celebrate outstanding individuals who

(NasdaqGM:BRNS), The final cohort of the single ascending dose (SAD) part of the Phase 1 AVALON trial initiated, with the SAD data readout expected early in the fourth quarter of 2025; The multiple ascending dose (MAD) part of the AVALON trial initiated; Available resources and cash runway guidance into 2027 remains unchanged. GERMANTOWN, Md., Aug.

— Tether Ventures, the independent investment arm of Tether, the largest company in the digital asset industry and issuer of the world's most capitalized stablecoin -USDT-has acquired a minority stake in Bit2Me and is leading a €30 million investment round. — Bit2Me has become the first Spanish-speakingfintech to receive authorization from Spain's CNMV to operate

Global revenues increase 61%; Net income increases 208% Leatt Corporation (OTCQB: LEAT), a leading developer and marketer of head-to-toe protective equipment for MOTO, MTB, and a wide range of extreme and high-velocity sports, today announced financial results for the second quarter ending June 30, 2025. All financial numbers are in U.S. dollars. Second Quarter 2025

LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) — Tidewave Bio, a biotechnology company developing a novel immune activation platform for solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has accepted its request for an INTERACT meeting, scheduled for August 2025. This regulatory milestone marks a critical step in Tidewave's effort to

(TSX:LAS-A.TO),(TSX:LAS.A), ROUGEMONT, Quebec, Aug. 07, 2025 (GLOBE NEWSWIRE) — Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) is pleased to announce that it will host a conference call to discuss its financial results for the second quarter of 2025 on Friday, August 8, 2025. Mr. Vince Timpano, Chief Executive Officer, and Mr. Eric Gemme,

Collaboration brings together ASC management expertise and tech-enabled revenue cycle services to help ASCs scale with confidence SYNERGEN Health, a leading provider of technology-enabled revenue cycle management (RCM) services and solutions, today announced a strategic collaboration with Compass Surgical Partners, a premier development and management partner of independent ambulatory surgery centers (ASCs). https://mma.prnewswire.com/media/2745852/SYNERGEN_Health_Logo.jpg Through this

Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, today announced financial results for the second quarter ended June 30, 2025, and provided recent corporate progress. “We're pleased with the progress made in Q2 to advance our ADC portfolio and remain